Clinical trial
A Study of Ramosetron Plus DX, Dexamethasone, Compared to Granisetron Plus DX…
NCT00272285 · Astellas Pharma Inc, Industry · Completed
Key facts
| NCT number | NCT00272285 |
|---|---|
| Title | A Study of Ramosetron Plus DX, Dexamethasone, Compared to Granisetron Plus DX for the Prevention of Vomiting and Nausea |
| Official title | A Double-blind, Randomized, Parallel, Comparative Study to Evaluate the Efficacy and Safety of Ramosetron Plus Dexamethasone Injection for the Prevention of Chemotherapy-Induced Vomiting and Nausea |
| Lead sponsor | Astellas Pharma Inc, Industry |
| Collaborators | Astellas Pharma Taiwan, Inc. Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Vomiting, Nausea |
| Intervention type | Drug |
| Interventions | Ramosetron, Granisetron |
| Enrollment | 287 |
| Start date | Jan 1, 2006 |
| Primary completion | Dec 1, 2007 |
| Completion | Mar 1, 2008 |
| First posted | Jan 5, 2006 |
| Last update posted | Mar 9, 2017 |
| Countries | Taiwan |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: